MAPT and neurodegenerative disease: In addition, biomarkers such as tau and blood neurofilament light protein were shown to be useful in the specific field of neurodegenerative diseases [7], while others, including S100B, covers a wider spectrum of neurological diseases, including traumatic brain injury, subarachnoid hemorrhage, epilepsy and neurodegenerative diseases [8, 9].